Amubarvimab Antibody
Amubarvimab (BRII-196) is a humanized monoclonal antibody that neutralizes SARS-CoV-2 by binding to the virus's spike protein. It has been investigated in both in vitro antiviral assays and in vivo preclinical models for the treatment of COVID-19.
Product Specifications
Product Name Alternative
BRII196, BRII-196
Target
SARS-CoV
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
4.78 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.84 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036478-ML405 100 µL
HDAC3, CT (HDAC3, Histone deacetylase 3, RPD3-2, SMAP45) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
IHULXNRNFCLY10UG 1 Each
Human Latexin Recombinant Protein N-Fc Tag Lyophilized
Sign In for Pricing
View Details